• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ECYT:US

18.1500 USD 0.5000 2.68%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Endocyte Inc (ECYT)

Open: 18.5100 Day's Range: 17.8200 - 19.2000 Volume: 952,764
Previous Close: 18.6500 52wk Range: 8.1800 - 33.7000 1-Yr Rtn: +29.64%

Stock Chart for ECYT

No chart data available.
  • ECYT:US 18.1500
  • 1D
  • 1M
  • 1Y
18.6500
Interactive ECYT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ECYT

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.5000
Est. EPS (USD) (12/2014) -0.2060
Est. PEG Ratio -
Market Cap (M USD) 737.90
Shares Outstanding (M) 40.66
30 Day Average Volume 1,974,594
Price/Book (mrq) 7.3891
Price/Sale (ttm) 10.0837
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/02/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ECYT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ECYT

Endocyte Inc. is a biopharmaceutical company developing targeted therapies for the treatment of cancer and inflammatory diseases. The Company uses a proprietary technology to create small molecule drug conjugates, or SMDCs, and companion imaging diagnostics that actively target receptors that are over-expressed on diseased cells, relative to healthy cells.

P Ron EllisPresident/CEO/Co-FounderMichael A ShermanChief Financial Officer
Philip S LowChief Science OfficerDavid D MeekChief Commercial Officer
More Company Profile & Key Executives for ECYT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil